Inoue M, Ando D, Kamada H, Taki S, Niiyama M, Mukai Y, Tadokoro T, Maenaka K, Nakayama T, Kado Y, Inoue T, Tsutsumi Y, Tsunoda S.: A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification. J Biol Chem. 292(16): 6438, 2017

Nagano T, Nagano K, Nabeshi H, Yoshida T, Kamada H, Tsunoda SI, Gao JQ, Higashisaka K, Yoshioka Y, Tsutsumi Y. Modifying the Surface of Silica Nanoparticles with Amino or Carboxyl Groups Decreases Their Cytotoxicity to Parenchymal Hepatocytes. Biol Pharm Bull. 40(5):726, 2017

（その他）
鎌田春彦, プロテオーム解析による疾患マーカーの開発, in silico創薬, 441-449. 2018

鎌田春彦, 機能性ペプチドの創製技術, ペプチド医薬品のスクリーニング・安定化・製剤化技術, 191-199, 2017



永田　諭志
Khan S, Sikander M, Ebeling MC, Ganju A, Kumari S, Yallapu MM, Hafeez BB, Ise T, Nagata S, Zafar N, Behrman SW, Wan JY, Ghimire HM, Sahay P, Pradhan P, Chauhan SC, Jaggi M., MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. Oncogene. 36(4):491-500, 2017